Journal Information
Original Article
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry
Jakub Gregora, Yochai Adirb, Martina Šterclovác, Nesrin Mogulkocd, Mordechai R. Kramere, Martina Doubkováf, Martina Plačkovág, Veronika Müllerh, Michael Studnickai, Monika Žurkováj, Ladislav Lacinak, Katarzyna Lewandowskal, Vladimír Bartošm, Petra Ovesnáa, Ondřej Májeka, Martina Koziar Vašákovác,
Corresponding author
a Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
b Carmel Medical Center, Haifa, Israel
c Department of Respiratory Medicine, Thomayer University Hospital, Prague, Czech Republic
d Department of Chest Diseases, Faculty of Medicine, Ege University, Izmir, Turkey
e Rabin Medical Centre, Petah Tikva, Israel
f Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic
g Department of Pneumology, University Hospital Ostrava, Czech Republic
h Department of Pulmonology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
i Department of Respiratory Medicine, Paracelsus Medical University Salzburg, Austria
j Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic
k Department of Pneumology and Thoracic Surgery, Hospital Na Bulovce, Prague, Czech Republic
l First Department of Pulmonary Diseases, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
m Department of Pneumology, University Hospital Hradec Králové, Czech Republic
Ver más